GONAL-F 77 MCG
FOLLITROPIN ALFA : 77 MCG · DIN 02248157 · EMD SERONO, A DIVISION OF EMD INC., CANADA
Health Canada status: CANCELLED POST MARKET
What is GONAL-F?
GONAL-F 77 MCG contains FOLLITROPIN ALFA : 77 MCG. It is listed in the Health Canada Drug Product Database under DIN 02248157, held by EMD SERONO, A DIVISION OF EMD INC., CANADA, supplied as POWDER FOR SOLUTION for INTRAMUSCULAR ; SUBCUTANEOUS administration. Health Canada currently lists it as cancelled post market, status dated 30-Apr-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02248157 |
|---|---|
| Brand name | GONAL-F |
| Generic / active ingredient | FOLLITROPIN ALFA : 77 MCG |
| Manufacturer | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Strength | 77 MCG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR ; SUBCUTANEOUS |
| Schedule | Schedule D |
| ATC code | G03GA05 FOLLITROPIN ALFA |
| AHFS class | 68:18.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Apr-2019 |
| Original market date | 2003-12-30 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code G03GA05 FOLLITROPIN ALFA. 3 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| GONAL-F PEN | 300 UNIT / 0.5 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED | DIN 02270404 |
| GONAL-F PEN | 450 UNIT / 0.75 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED | DIN 02270390 |
| GONAL-F PEN | 900 UNIT / 1.5 ML | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED | DIN 02270382 |
| GONAL-F | 1200 UNIT | POWDER FOR SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02244787 |
| GONAL-F | 150 UNIT | POWDER FOR SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02231465 |
| GONAL-F | 33 MCG | POWDER FOR SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02248156 |
| GONAL-F | 37.5 UNIT | POWDER FOR SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02243004 |
| GONAL-F | 5.5 MCG | POWDER FOR SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02248154 |
| GONAL-F | 75 UNIT | POWDER FOR SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | CANCELLED POST MARKET | DIN 02231464 |
Who else supplies FOLLITROPIN ALFA worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FOLLITROPIN ALFA appears in 53 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.